S4 Andarine + Cardarine Capsules

Buy S4 Andarine + Cardarine Capsules Online

S4 Andarine + Cardarine combines Andarine (S-4), a selective androgen receptor modulator, with Cardarine (GW501516), a PPARδ agonist. The combination brings together androgen-receptor and metabolic-signaling research pathways.

Product Information

Andarine has been investigated as a selective androgen receptor modulator designed to produce tissue-selective androgen-receptor activity. Cardarine acts through PPARδ and has been studied for effects on fatty-acid oxidation and lipid metabolism. The combination itself does not have established clinical trial evidence.

How It Works

Andarine interacts with androgen receptors, while Cardarine activates PPARδ, a nuclear receptor involved in lipid metabolism and fatty-acid utilization. These mechanisms are pharmacologically distinct and therefore represent two separate research pathways in the blend.

POTENTIAL BENEFITS

1. Androgen-Receptor Research

Andarine provides a model for investigating selective androgen-receptor activation. Research has focused on its interaction with androgen-responsive tissues and its potential anabolic properties.

2. Lipid-Metabolism Research

Cardarine has been studied for its ability to activate PPARδ and alter lipid-related gene expression. Human research has demonstrated measurable changes in HDL and triglyceride-related parameters.

3. Fatty-Acid Oxidation Research

PPARδ activation is closely associated with fatty-acid utilization and oxidative metabolism in skeletal muscle. Cardarine research has therefore focused heavily on metabolic flexibility and lipid handling.

4. Dual-Pathway Research

The combination is relevant to research examining androgen signaling alongside metabolic pathways. However, evidence for each component should be considered separately because the exact S4 + Cardarine combination has not been clinically validated.

Dosage

There is no established dosage for the S4 Andarine + Cardarine combination. Human research involving GW501516 has evaluated 2.5, 5, and 10 mg/day, while comparable controlled human dosing data for Andarine are not sufficient to establish a validated clinical regimen. These component-specific research exposures should not be treated as a recommended combination dose.

Side Effects

Andarine research has raised concerns involving hormonal effects and visual disturbances, while Cardarine development was discontinued after serious safety concerns emerged in long-term animal studies. The combination therefore has no established long-term human safety profile.

References

1. Thevis M, et al. *Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4).*
2. Rothman MS, et al. *Triglyceride lipoprotein cholesterol effects in healthy subjects administered a PPARδ agonist.*
3. Sprecher DL, et al. *Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516.*
4. GW501516 and metabolic effects in moderately obese men.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.